The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gene Panel-Global Market Insights and Sales Trends 2024
Synopsis
A gene panel is a test that analyzes multiple genes at once for cancer-associated mutations.
The global Gene Panel market size is expected to reach US$ 3365.6 million by 2029, growing at a CAGR of 15.6% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Panel in various end use industries. The expanding demands from the Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Others, are propelling Gene Panel market. Amplicon-based Approach, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hybridization-based Approach segment is estimated at % CAGR for the next seven-year period.
In 2017, North America dominated the market, followed by Europe. The large share of the North American market can be majorly attributed to the government support for genomics research. Other growth factors include the presence of leading NGS providers, growing research on cancer and inherited rare diseases, and increasing number of NGS-based & clinical applications in the region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Panel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Panel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Panel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Panel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Panel covered in this report include Illumina, Thermo Fisher, Agilent, Qiagen, Eurofins Scientific, BGI, Roche, Integrated Dna Technologies and Genewiz, etc.
The global Gene Panel market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher
Agilent
Qiagen
Eurofins Scientific
BGI
Roche
Integrated Dna Technologies
Genewiz
Novogene
Personalis
Gatc Biotech
Archerdx
Global Gene Panel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Panel market, Segment by Type:
Amplicon-based Approach
Hybridization-based Approach
Global Gene Panel market, by Application
Cancer Risk Assessment
Diagnosis of Congenital Diseases
Pharmacogenetics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Panel companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A gene panel is a test that analyzes multiple genes at once for cancer-associated mutations.
The global Gene Panel market size is expected to reach US$ 3365.6 million by 2029, growing at a CAGR of 15.6% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Panel in various end use industries. The expanding demands from the Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Others, are propelling Gene Panel market. Amplicon-based Approach, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hybridization-based Approach segment is estimated at % CAGR for the next seven-year period.
In 2017, North America dominated the market, followed by Europe. The large share of the North American market can be majorly attributed to the government support for genomics research. Other growth factors include the presence of leading NGS providers, growing research on cancer and inherited rare diseases, and increasing number of NGS-based & clinical applications in the region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Panel, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Panel market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Panel market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Panel sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Panel covered in this report include Illumina, Thermo Fisher, Agilent, Qiagen, Eurofins Scientific, BGI, Roche, Integrated Dna Technologies and Genewiz, etc.
The global Gene Panel market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher
Agilent
Qiagen
Eurofins Scientific
BGI
Roche
Integrated Dna Technologies
Genewiz
Novogene
Personalis
Gatc Biotech
Archerdx
Global Gene Panel market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Panel market, Segment by Type:
Amplicon-based Approach
Hybridization-based Approach
Global Gene Panel market, by Application
Cancer Risk Assessment
Diagnosis of Congenital Diseases
Pharmacogenetics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Panel companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gene Panel
1.1 Gene Panel Market Overview
1.1.1 Gene Panel Product Scope
1.1.2 Gene Panel Market Status and Outlook
1.2 Global Gene Panel Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Panel Market Size by Region (2018-2029)
1.4 Global Gene Panel Historic Market Size by Region (2018-2023)
1.5 Global Gene Panel Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Panel Market Size (2018-2029)
1.6.1 North America Gene Panel Market Size (2018-2029)
1.6.2 Europe Gene Panel Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Panel Market Size (2018-2029)
1.6.4 Latin America Gene Panel Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Panel Market Size (2018-2029)
2 Gene Panel Market by Type
2.1 Introduction
2.1.1 Amplicon-based Approach
2.1.2 Hybridization-based Approach
2.2 Global Gene Panel Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Panel Historic Market Size by Type (2018-2023)
2.2.2 Global Gene Panel Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Panel Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Panel Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Panel Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Panel Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Panel Revenue Breakdown by Type (2018-2029)
3 Gene Panel Market Overview by Application
3.1 Introduction
3.1.1 Cancer Risk Assessment
3.1.2 Diagnosis of Congenital Diseases
3.1.3 Pharmacogenetics
3.1.4 Others
3.2 Global Gene Panel Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Panel Historic Market Size by Application (2018-2023)
3.2.2 Global Gene Panel Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Panel Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Panel Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Panel Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Panel Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Panel Revenue Breakdown by Application (2018-2029)
4 Gene Panel Competition Analysis by Players
4.1 Global Gene Panel Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Panel as of 2022)
4.3 Date of Key Players Enter into Gene Panel Market
4.4 Global Top Players Gene Panel Headquarters and Area Served
4.5 Key Players Gene Panel Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Panel Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina Gene Panel Products, Services and Solutions
5.1.4 Illumina Gene Panel Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Profile
5.2.2 Thermo Fisher Main Business
5.2.3 Thermo Fisher Gene Panel Products, Services and Solutions
5.2.4 Thermo Fisher Gene Panel Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Recent Developments
5.3 Agilent
5.3.1 Agilent Profile
5.3.2 Agilent Main Business
5.3.3 Agilent Gene Panel Products, Services and Solutions
5.3.4 Agilent Gene Panel Revenue (US$ Million) & (2018-2023)
5.3.5 Qiagen Recent Developments
5.4 Qiagen
5.4.1 Qiagen Profile
5.4.2 Qiagen Main Business
5.4.3 Qiagen Gene Panel Products, Services and Solutions
5.4.4 Qiagen Gene Panel Revenue (US$ Million) & (2018-2023)
5.4.5 Qiagen Recent Developments
5.5 Eurofins Scientific
5.5.1 Eurofins Scientific Profile
5.5.2 Eurofins Scientific Main Business
5.5.3 Eurofins Scientific Gene Panel Products, Services and Solutions
5.5.4 Eurofins Scientific Gene Panel Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Scientific Recent Developments
5.6 BGI
5.6.1 BGI Profile
5.6.2 BGI Main Business
5.6.3 BGI Gene Panel Products, Services and Solutions
5.6.4 BGI Gene Panel Revenue (US$ Million) & (2018-2023)
5.6.5 BGI Recent Developments
5.7 Roche
5.7.1 Roche Profile
5.7.2 Roche Main Business
5.7.3 Roche Gene Panel Products, Services and Solutions
5.7.4 Roche Gene Panel Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Recent Developments
5.8 Integrated Dna Technologies
5.8.1 Integrated Dna Technologies Profile
5.8.2 Integrated Dna Technologies Main Business
5.8.3 Integrated Dna Technologies Gene Panel Products, Services and Solutions
5.8.4 Integrated Dna Technologies Gene Panel Revenue (US$ Million) & (2018-2023)
5.8.5 Integrated Dna Technologies Recent Developments
5.9 Genewiz
5.9.1 Genewiz Profile
5.9.2 Genewiz Main Business
5.9.3 Genewiz Gene Panel Products, Services and Solutions
5.9.4 Genewiz Gene Panel Revenue (US$ Million) & (2018-2023)
5.9.5 Genewiz Recent Developments
5.10 Novogene
5.10.1 Novogene Profile
5.10.2 Novogene Main Business
5.10.3 Novogene Gene Panel Products, Services and Solutions
5.10.4 Novogene Gene Panel Revenue (US$ Million) & (2018-2023)
5.10.5 Novogene Recent Developments
5.11 Personalis
5.11.1 Personalis Profile
5.11.2 Personalis Main Business
5.11.3 Personalis Gene Panel Products, Services and Solutions
5.11.4 Personalis Gene Panel Revenue (US$ Million) & (2018-2023)
5.11.5 Personalis Recent Developments
5.12 Gatc Biotech
5.12.1 Gatc Biotech Profile
5.12.2 Gatc Biotech Main Business
5.12.3 Gatc Biotech Gene Panel Products, Services and Solutions
5.12.4 Gatc Biotech Gene Panel Revenue (US$ Million) & (2018-2023)
5.12.5 Gatc Biotech Recent Developments
5.13 Archerdx
5.13.1 Archerdx Profile
5.13.2 Archerdx Main Business
5.13.3 Archerdx Gene Panel Products, Services and Solutions
5.13.4 Archerdx Gene Panel Revenue (US$ Million) & (2018-2023)
5.13.5 Archerdx Recent Developments
6 North America
6.1 North America Gene Panel Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gene Panel Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Panel Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Panel Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Panel Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Panel Market Dynamics
11.1 Gene Panel Industry Trends
11.2 Gene Panel Market Drivers
11.3 Gene Panel Market Challenges
11.4 Gene Panel Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
